Where does 410 Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), 410 Medical, Inc. ranks #25,618 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does 410 Medical, Inc. hold?

410 Medical, Inc. holds 10 US utility patents granted between 2018 and 2024, spanning 7 technology areas.

What is 410 Medical, Inc.'s Innovation Score?

410 Medical, Inc. has an Innovation Score of 40.3 out of 100 (top 36% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is 410 Medical, Inc.'s patent grant rate increasing or decreasing?

410 Medical, Inc.'s recent grant velocity is +133% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for 410 Medical, Inc.'s patents?

410 Medical, Inc.'s patents average 23.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the 410 Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

410 Medical, Inc.

Q: What technology areas does 410 Medical, Inc. focus on?

410 Medical, Inc.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 10 patents, ranking #701 of 3,490 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

USPTO PatentsView assignee record - 10 granted patents across 7 technology areas, recorded in grant years 2018–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, 410 ranks #25,618 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 7 technology areas.

#25,618
of 49,997 US assignees by volume: Top 36%
by Innovation Score (40.3/100): 23.9
avg claims per patent: +133%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R25618 · US Corporation #25,618 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #25,618/49,997
PHOTO-FINISH 1ST Biotherapeutics
CPC-NARROW A61M · 7 areas
INNOV-PAR 40.3/100
CLAIMS-DENSE 23.9 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +133% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: 1ST Biotherapeutics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How 410’s 40.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (21%) Velocity 8.3 pts (21%) Breadth 9.4 pts (23%) Claim depth 14.3 pts (35%)

Qualcomm Incorporated · highest

85
410 Medical · this assignee

40
3D Lighting… · lowest

7

What this shows 410's Innovation Score is 40.3/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for 410?

Each dot is one of 410’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). 410’s own 23.9 claims/patent is ABOVE the 15.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

410 vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where 410's grants concentrate

410 Medical, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2019 (2 grants) versus a trough of 1 in 2018. By volume, 410 sits between 1ST Biotherapeutics, Inc. and 9155-0020 Quebec Inc..

410's three-year grant acceleration

410 Medical, Inc. shows 5 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

1ST Biotherapeuti…

10
1st Defence Indus…

10
2nd Skull

10
3D Plus

10
4DS Memory

10
7tunnels

10
80 Percent Arms

10
9155-0020 Quebec

10
410 Medical ◀

10

What this shows 410 holds 10 patents at rank #25,618, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near 410

By rank, the assignees closest to #25,618 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in 410's primary technology class.

410's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

410 Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	10.0%
2019	2	20.0%
2020	2	20.0%
2022	1	10.0%
2023	2	20.0%
2024	2	20.0%

Which technologies does 410 Medical, Inc. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 10

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

G05D - Systems FOR Controlling OR Regulating Non-electric Variables 2

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 2

F16K - VALVES; TAPS; COCKS; ACTUATING-FLOATS; Devices FOR Venting OR Aerating 2

B01D - Separation 2

A61B - DIAGNOSIS; SURGERY; Identification 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

410 Medical, Inc.'s patent record in context - here's where to go next.

410 Medical, Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 100% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #25,618 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare 410 Medical, Inc. against 1ST Biotherapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.